Prescribed Knee Brace Treatments for Osteoarthritis of the Knee (Knee OA)

August 6, 2025 updated by: Össur Iceland ehf

Behandlingseffekter Med Avlastande knäortoser för Patienter Med knäartros En Retro-och Prospektiv Multicenterregisterstudie

The study is a non-controlled retro- and prospective multi center patient registry study.

Subjects will be given a study ID number assigned at first brace fitting after consenting to partake. Participants will be asked to fill in a questionnaire either in electronic or paper version at first fitting. Additional follow up questionnaires will be implemented at 4 weeks, 6 months and 1 year post initial brace fitting. After that period patients will be contacted every year, until brace termination/ knee surgery or death.

Study Overview

Status

Enrolling by invitation

Conditions

Detailed Description

This is a noninterventional registry study pertaining to knee OA braces. There are no comparative devices or treatments. Subjects are expected to follow the recommendations of the brace subscriber and other health care professionals at any time independent of their continuation within the registry.

Subjects will be enrolled at the clinic where their brace was prescribed or at the site where the brace was fitted.

There is no formal end date for this data registry. A revisit to this protocol may be motivated after 5 years, to assess if longer follow up is required.

For individual participants follow up will continue with annual questionnaires as long as the brace is in use. The questionnaires will be administered either through mail with a paper version, or through a link to an electronical version (ePRO). There is also a possibility of administrating the questionnaires as a phone guided interview, if that is a mean that serves the patient or clinics better. The planned follow-ups are at 4 weeks, 6 months, 1 year from brace prescription and then annually as long as participants are disposed as "ongoing" in the registry.

The questionnaires contains question about pain, function, medication, general brace use and quality of life question.

Study Type

Observational

Enrollment (Estimated)

1500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Skåne
      • Hässleholm, Skåne, Sweden
        • Skånevård Nordost Region Skåne - Verksamhets område ortopedi, Kristianstad /Hässleholm

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Subjects are patients that have been prescribed knee braces for treatment of knee OA. The brace prescription is independent of the registry, i.e. no one is prescribed a brace because of the registry or for the purpose of this data collection per se

Description

Inclusion Criteria:

  • Patients that are prescribed knee brace for symptomatic treatment of knee OA from partaking clinics
  • Older than 18 years

Exclusion Criteria:

  • Younger than 18 years
  • Not willing or able to sign informed consent, or not cognitive impairments preventing understanding of the questionnaires.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of patients that are using the braces
Time Frame: 6 months follow up
brace usage, days per week
6 months follow up
Change in Pain status compared to baseline
Time Frame: 6 months follow up
Knee injury and Osteoarthritis Outcome Score (KOOS)-12
6 months follow up
Change in Mobility compared to baseline
Time Frame: 6 months follow up
KOOS-12
6 months follow up
Proportion of patients that are still using the braces
Time Frame: 1 year follow up
brace usage, days per week
1 year follow up
Change in Pain status compared to baseline
Time Frame: 1 year follow up
KOOS-12
1 year follow up
Change in Mobility compared to baseline
Time Frame: 1 year follow up
KOOS-12
1 year follow up
Sick leave after receiving the braces
Time Frame: 6 months follow up
Proportion of sick leave
6 months follow up
Sick leave after receiving the braces
Time Frame: 1 year follow up
Proportion of sick leave
1 year follow up
Changes in reported quality of life
Time Frame: 6 months follow up
KOOS-12
6 months follow up
Changes in reported quality of life
Time Frame: 1 year follow up
KOOS-12
1 year follow up
Changes in QALY's
Time Frame: 6 months follow up
EQ-5D-5L
6 months follow up
Changes in QALY's
Time Frame: 1 year follow up
EQ-5D-5L
1 year follow up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
The patients' satisfaction of the value/effectiveness of the brace
Time Frame: 6 months follow up
Numeric Rating Scale (NRS) for satisfaction (0-10)
6 months follow up
The patients' satisfaction of the value/effectiveness of the brace
Time Frame: 1 year follow up
NRS for satisfaction (0-10)
1 year follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Samuel Dencker, Dr, Region Skane

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 9, 2020

Primary Completion (Estimated)

December 31, 2030

Study Completion (Estimated)

December 31, 2030

Study Registration Dates

First Submitted

November 18, 2020

First Submitted That Met QC Criteria

November 25, 2020

First Posted (Actual)

December 3, 2020

Study Record Updates

Last Update Posted (Actual)

August 11, 2025

Last Update Submitted That Met QC Criteria

August 6, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • CIP2020050839

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on This is a non interventional registry

Subscribe